Gilead Sciences (NASDAQ:GILD) has reached settlement agreements with Lupin, Cipla, and Laurus Labs to resolve patent disputes related to Biktarvy, a medication for HIV. These companies had sought approval from the U.S. Food and Drug Administration to produce generic versions of ...